Unknown

Dataset Information

0

Pharmacokinetics and Toxicity in Rats and Monkeys of coDbait: A Therapeutic Double-stranded DNA Oligonucleotide Conjugated to Cholesterol.


ABSTRACT: Increased DNA repair activity in cancer cells is one of their primary mechanisms of resistance to current radio- and chemotherapies. The molecule coDbait is the first candidate in a new class of drugs that target the double-strand DNA break repair pathways with the aim of overcoming these resistances. coDbait is a 32-base pair (bp) double-stranded DNA molecule with a cholesterol moiety covalently attached to its 5'-end to facilitate its cellular uptake. We report here the preclinical pharmacokinetic and toxicology studies of subcutaneous coDbait administration in rodents and monkeys. Maximum plasma concentration occurred between 2 to 4 hours in rats and at 4 hours in monkeys. Increase in mean AUC0-24h was linear with dose reaching 0.5 mg·h/ml for the highest dose injected (32?mg) for both rats and monkeys. No sex-related differences in maximum concentration (Cmax) nor AUC0-24h were observed. We extrapolated these pharmacokinetic results to humans as the subcutaneous route has been selected for evaluation in clinical trials. Tri-weekly administration of coDbait (from 8 to 32?mg per dose) for 4 weeks was overall well tolerated in rats and monkeys as no morbidity/mortality nor changes in clinical chemistry and histopathology parameters considered to be adverse effects have been observed.

SUBMITTER: Schlegel A 

PROVIDER: S-EPMC3411319 | biostudies-literature | 2012 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Pharmacokinetics and Toxicity in Rats and Monkeys of coDbait: A Therapeutic Double-stranded DNA Oligonucleotide Conjugated to Cholesterol.

Schlegel Anne A   Buhler Cyril C   Devun Flavien F   Agrario Céline C   Urien Saïk S   Lokiec François F   Sun Jian-Sheng JS   Dutreix Marie M  

Molecular therapy. Nucleic acids 20120731


Increased DNA repair activity in cancer cells is one of their primary mechanisms of resistance to current radio- and chemotherapies. The molecule coDbait is the first candidate in a new class of drugs that target the double-strand DNA break repair pathways with the aim of overcoming these resistances. coDbait is a 32-base pair (bp) double-stranded DNA molecule with a cholesterol moiety covalently attached to its 5'-end to facilitate its cellular uptake. We report here the preclinical pharmacokin  ...[more]

Similar Datasets

| S-EPMC5014515 | biostudies-literature
| S-EPMC7854292 | biostudies-literature
| S-EPMC3262748 | biostudies-literature
| S-EPMC7452107 | biostudies-literature
| S-EPMC4773231 | biostudies-literature
| S-EPMC10843171 | biostudies-literature
| S-EPMC4881758 | biostudies-literature
| S-EPMC6524780 | biostudies-literature
| S-EPMC3219224 | biostudies-literature
| S-EPMC6483862 | biostudies-literature